Study: ADRIATIC clinical trial results suggest durvalumab may offer a new path in small cell lung cancer care
Supporting oncology professionals through education
The content on this site is intended for healthcare professionals only
The content on this site is intended for healthcare professionals only
Study: ADRIATIC clinical trial results suggest durvalumab may offer a new path in small cell lung cancer care
Researchers help create largest immune cell atlas of bone marrow in multiple myeloma patients
Inflammatory immune cells predict survival, relapse in multiple myeloma
Inflammatory immune cells predict survival, relapse in multiple myeloma
Personalising cancer treatments significantly improve outcome success
Institute team identifies origin cells for malignant brain tumour common in young adults
Researchers find promising new way to boost the immune response to cancer
Patients with clonal haematopoiesis have increased heart disease risk following cancer treatment
Automate manufacturing of solid tumour CAR T cell therapy
Preoperative VEGFR-TKI plus ICI therapy facilitates 3D-guided cytoreductive nephron-sparing surgical feasibility and immune remodelling in advanced renal cell carcinoma
Short-circuiting pancreatic cancer
Research paves the way for safer colonoscopy bowel prep for people with compromised gut health